This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Shari M Ling: Innovator in Osteoarthritis Risk Evaluation
Introduction
Shari M Ling is a prominent inventor based in Ellicott City, MD (US). She has made significant contributions to the field of osteoarthritis research, particularly in developing methods for evaluating the risk of this condition. Her work is crucial for diagnosing osteoarthritis and assessing its progression.
Latest Patents
Shari M Ling holds a patent for "Methods for evaluating osteoarthritis risk." This patent outlines methods for diagnosing osteoarthritis, confirming diagnoses, assessing progression, determining severity, and evaluating the risk of developing osteoarthritis in the future. The methods involve measuring the activity of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) and interleukin-15 (IL-15). Additionally, her patent includes methods for identifying compounds that can alter the activity of OA-related molecules, paving the way for potential anti-osteoarthritis drugs.
Career Highlights
Shari M Ling is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in this capacity has allowed her to contribute significantly to public health and medical research.
Collaborations
Shari has collaborated with notable colleagues, including Dhavalkumar D Patel and Luigi Ferrucci. These collaborations have enhanced her research and expanded the impact of her innovations in the field of osteoarthritis.
Conclusion
Shari M Ling's innovative work in evaluating osteoarthritis risk has the potential to transform how this condition is diagnosed and treated. Her contributions are vital for advancing medical research and improving patient outcomes.